ArticleTherapeutic advances in drug safety2021

Validation of a novel causality assessment scale for adverse events in non-small cell lung carcinoma patients treated with platinum and pemetrexed doublet chemotherapy.

Jyoti Bhagatram Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.